Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,164,121
+$383,729 QoQ
Shares Held
12,574
-1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#1,621
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WIMMER ASSOCIATES 1, LLC holds $14,096,189 across 8 Drug Manufacturers - General names. ABBV ranks #1 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
12,574 | $3,164,121 | |
| 2 | AMGN |
Amgen Inc
|
8,431 | $3,053,033 | |
| 3 | LLY |
ELI LILLY & Co
|
2,470 | $2,962,592 | |
| 4 | JNJ |
Johnson & Johnson
|
9,705 | $2,464,778 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,952 | $1,407,332 | |
| 6 | NVS |
Novartis AG
|
2,594 | $406,531 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,110 | $392,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,250 | $244,885 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,164,121 | 12,574 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,780,392 | 12,784 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,966,257 | 12,982 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,069,757 | 13,258 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,507,354 | 13,508 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,927,832 | 13,974 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,628,716 | 14,793 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,031,910 | 15,353 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,640,893 | 15,397 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,803,793 | 15,397 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,582,110 | 16,662 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,453,825 | 16,462 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,223,179 | 16,501 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,637,732 | 16,551 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,743,652 | 16,977 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,280,093 | 16,989 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,618,423 | 17,096 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,798,504 | 17,263 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,283,250 | 16,863 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,789,563 | 16,590 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,864,079 | 16,549 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,787,253 | 16,515 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,790,155 | 16,707 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,472,738 | 16,814 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $1,557,822 | 15,867 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,291,649 | 16,953 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||